National Bank of Canada
RCUS icon

National Bank of Canada’s Arcus Biosciences RCUS Stock Holding History

National Bank of Canada’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$1.52K – 2990
2024
Q2 		$1.52K Hold
100
– – ﹤0.01% 2451
2024
Q1 		$1.66K Hold
100
– – ﹤0.01% 2476
2023
Q4 		$1.97K Hold
100
– – ﹤0.01% 2457
2023
Q3 		$1.71K Hold
100
– – ﹤0.01% 2525
2023
Q2 		$2.03K Hold
100
– – ﹤0.01% 2465
2023
Q1 		$1.82K Hold
100
– – ﹤0.01% 2454
2022
Q4 		$2.07K Hold
100
– – ﹤0.01% 2484
2022
Q3 		$3K Hold
100
– – ﹤0.01% 2457
2022
Q2 		$3K Hold
100
– – ﹤0.01% 2553
2022
Q1 		$3K Hold
100
– – ﹤0.01% 2664
2021
Q4 		$4K Buy
+100
New +$3.88K ﹤0.01% 2589

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

National Bank of Canada's RCUS Position: Q3 2024 in Review

National Bank of Canada sold out of Arcus Biosciences (RCUS) in Q3 2024, closing a stake of 100 shares — an estimated $1.52K sold.

National Bank of Canada first reported a position in RCUS in Q4 2021 and held it in 11 quarters. The position peaked at $4K in Q4 2021. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2024.

  • National Bank of Canada reported no remaining Arcus Biosciences position as of Q3 2024 after selling out during the quarter.
  • National Bank of Canada sold 100 Arcus Biosciences shares in Q3 2024, an estimated $1.52K.
  • National Bank of Canada first reported a position in Arcus Biosciences in Q4 2021 and held it in 11 quarters.
  • National Bank of Canada's Arcus Biosciences position peaked at $4K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2024.

Based on National Bank of Canada's 13F filing for Q3 2024, filed 12 Nov 2024.